Connect with us
The international patient-led organization “We, The Patients”, founded and chaired by Carola Pérez, will broaden the European debate on Medicinal Cannabis and Pain...
Editor's note: On October 13th at 2:43 PM, Pedro Sabaciauskis' statements regarding the meetings with the associations were included. During the 16th Public Meeting...
The European Food Safety Authority (EFSA) opened a public consultation on September 9th regarding the update of the safety declaration for...
Germany recently sent the European Commission a draft bill proposing to strengthen controls over cannabis prescriptions and dispensing...
The Spanish Council of Ministers has approved a new Royal Decree regulating the medicinal use of standardized cannabis preparations intended for compounding. The regulation...
The importance of medical education, the harmonization of products and European laws, and the co-payment of prescriptions for medicinal cannabis were three of the most discussed topics...
A study published in the Journal of Psychopharmacology contradicts the perception of cannabis users who believe they are fit to drive just a few hours after...
Epilepsy, as a chronic neurological disease, affects a substantial number of individuals globally, with a significant subset of patients demonstrating an unsatisfactory response...
SOMAÍ Pharmaceuticals, a multinational operator with EU-GMP certification, through a partnership with Universidade Lusófona, has published a peer-reviewed study in the renowned journal...
A systematic review entitled “The differential effects of medicinal cannabis on mental health” carried out by researchers at Erasmus University Rotterdam in the Netherlands addresses the role...
Watch the Documentary "Patients" by Laura Ramos
